share_log

Wells Fargo Maintains Equal-Weight on Ironwood Pharmaceuticals, Raises Price Target to $13

Benzinga Real-time News ·  Aug 16, 2022 07:44

Wells Fargo analyst Jacob Hughes maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Equal-Weight and raises the price target from $12 to $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment